HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinoma

Heidi Koskela, Yilin Li, Titta Joutsiniemi, Taru Muranen, Veli Matti Isoviita, Kaisa Huhtinen, Giulia Micoli, Kari Lavikka, Giovanni Marchi, Sakari Hietanen, Anni Virtanen, Sampsa Hautaniemi, Jaana Oikkonen, Johanna Hynninen

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalGynecologic Oncology
Volume180
Pages (from-to)91-98
Number of pages8
ISSN0090-8258
DOIs
Publication statusPublished - Jan 2024
MoE publication typeA1 Journal article-refereed

Bibliographical note

Publisher Copyright:
© 2023 The Authors

Fields of Science

  • Genetic testing
  • High-grade serous ovarian cancer (HGSC)
  • Homologous-recombination-deficiency (HRD)
  • Platinum
  • Whole-genome-sequencing (WGS)
  • 3122 Cancers
  • 3123 Gynaecology and paediatrics

Cite this